immuno-oncology Archives

Sillajen explains Pexa-Vec trial failure – it was the rescue meds

https://pharmaphorum.com/news/sillajen-explains-pexa-vec-trial-failure-it-was-the-rescue-meds/

Roche scores with Tecentriq combo in first-line bladder cancer

https://pharmaphorum.com/news/roche-scores-with-tecentriq-combo-in-first-line-bladder-cancer/

Exicure lists on Nasdaq, raising $55m for cancer, neurology push

https://pharmaphorum.com/news/exicure-lists-on-nasdaq-raising-55m-for-cancer-neurology-push/

Roche closes on EU approval for Tecentriq in breast cancer

https://pharmaphorum.com/news/roche-closes-on-eu-approval-for-tecentriq-in-breast-cancer/

Change at the top at Adaptimmune as Noble stands down

https://pharmaphorum.com/news/change-at-the-top-at-adaptimmune-as-noble-stands-down/

Gilead joins protein degradation drive with Nurix deal

https://pharmaphorum.com/news/gilead-joins-protein-degradation-drive-with-nurix-deal/

Merck and Pfizer stop third Bavencio ovarian cancer trial

https://pharmaphorum.com/news/merck-and-pfizer-stop-third-bavencio-ovarian-cancer-trial/

Cell Mogrify gets £420k funding for regenerative cell therapies

https://pharmaphorum.com/news/cell-mogrify-gets-420k-funding-for-regenerative-cell-therapies/

Immuno-Oncology 2018 News: MHRA Interview and New Speaker ImmuneBiotech AB Announced

https://pharmaphorum.com/partner-content/immuno-oncology-2018-news-mhra-interview-and-new-speaker-immunebiotech-ab-announced/

Search